These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1971589)

  • 1. Echocardiographic assessment of lack of beta 1-receptor down-regulation during prolonged therapy with xamoterol.
    Cheron P; Nannan M; Pouleur H; Rousseau MF
    Eur Heart J; 1990 Apr; 11 Suppl A():46-7. PubMed ID: 1971589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of xamoterol and digoxin in patients with mild to moderate heart failure. The Italian Xamoterol Multicenter Research Group.
    Eur Heart J; 1990 Apr; 11 Suppl A():50-1. PubMed ID: 1971591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of xamoterol on exercise capacity and left ventricular function in angina pectoris and in dilated cardiomyopathy.
    Boström PA; Johansson BW; Lecerof H; Lilja B; Torp A
    Eur Heart J; 1990 Apr; 11 Suppl A():45. PubMed ID: 1971588
    [No Abstract]   [Full Text] [Related]  

  • 4. Illustration of the effects of long-term xamoterol therapy on the time course of left ventricular pressure.
    van Mechelen H; Ries A; Pouleur H; Rousseau MF
    Eur Heart J; 1990 Apr; 11 Suppl A():67-9. PubMed ID: 1971598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac beta-adrenoceptor regulation and the effects of partial agonism.
    Barnett DB; Lu XY
    Am J Cardiol; 1991 May; 67(12):18C-19C. PubMed ID: 1673585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in exercise tolerance and resting haemodynamics during long-term treatment of heart failure with xamoterol.
    Kayanakis JG; Courtault L; Fauvel JM; Boundhoure JP; Snow HM
    Eur Heart J; 1990 Apr; 11 Suppl A():52-3. PubMed ID: 2140552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of xamoterol in moderate ischemic cardiac insufficiency].
    Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F
    Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
    Heng MK
    Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol.
    Brodde OE; Daul A; Michel-Reher M; Boomsma F; Man in 't Veld AJ; Schlieper P; Michel MC
    Circulation; 1990 Mar; 81(3):914-21. PubMed ID: 1968366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of xamoterol on haemodynamics and plasma catecholamines in chronic heart failure.
    Ollivier JP; Ricordei I; Bayon P; Popelard P; Moyse D; de Bourayne J; Dupont C; Droniou J
    Eur Heart J; 1990 Apr; 11 Suppl A():59-60. PubMed ID: 1971594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacology of xamoterol: a basis for modulation of the autonomic control of the heart.
    Snow HM
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):3S-13S. PubMed ID: 2572252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xamoterol monotherapy in heart failure. The European 'Corwin' Group.
    Timewell RM; Stark RD; Marlow HF
    Eur Heart J; 1990 Apr; 11 Suppl A():62-4. PubMed ID: 1971596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A patient-powered treadmill--a simple alternative means of assessing heart failure and treatment in family practice.
    Tweed JA; Causer MS; Gostick NK; Jones BP; Korlipara K; Mayhew SR; Saul PA; Wright FW
    Eur Heart J; 1990 Apr; 11 Suppl A():65-6. PubMed ID: 1971597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xamoterol: stabilising the cardiac beta receptor?
    Lancet; 1988 Dec; 2(8625):1401-2. PubMed ID: 2904527
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant xamoterol or metoprolol in patients with malignant ventricular arrhythmia resistant to amiodarone.
    Paul V; Griffith M; Ward DE; Camm AJ
    Lancet; 1989 Aug; 2(8658):302-5. PubMed ID: 2569105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic modulation in practice: the German clinical experience.
    Kupper W; Erlemeier HH; Bleifeld W
    Eur Heart J; 1990 Apr; 11 Suppl A():19-25. PubMed ID: 1971586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
    Virk SJ; Davies MK
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
    Richaud M; Lechat P; Komajda M; Landault C; Fournier P; Fraysse JB; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1990 Feb; 83(2):247-52. PubMed ID: 1968739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xamoterol and the failing heart.
    Davies MK
    Lancet; 1990 Jan; 335(8681):117-8. PubMed ID: 1967408
    [No Abstract]   [Full Text] [Related]  

  • 20. Xamoterol in hypertrophic cardiomyopathy: effects on diastolic function and heart rate.
    Gilligan DM; Stewart R; Chan WL; Oakley CM
    Int J Cardiol; 1992 Jun; 35(3):377-86. PubMed ID: 1351887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.